Indefinite Delivery Contract 36E79720D0013
- Not listed
- Golden State Medical Supply, Inc. was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs (VA) National Acquisition Center on November 17, 2021, to supply mesalamine tablets at a ceiling value of $83.9 million through November 16, 2026. The contract encompasses a one-year base period from November 17, 2021 to November 16, 2022, with four optional one-year renewal periods. The solicitation, posted as a pre-solicitation notice on June 3, 2021, specified the...
- The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract to Avkare, LLC, a for-profit limited liability company, to provide abiraterone tablets. This 1-year base contract with four 1-year option periods has a potential value of $70,208,375.13. The contract will supply the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) with an uninterrupted source of abiraterone acetate 250mg tablets, with an...
- The Department of Veterans Affairs National Acquisition Center awarded Avkare, LLC a single-award indefinite delivery contract with a potential value of $14,965,328.90 to supply entecavir tablets. The contract utilizes no set-asides and has a base period of performance from December 28, 2020 to December 27, 2021, including four one-year option periods extending to December 27, 2025. The originating pre-solicitation notice sought offers for an unrestricted procurement of entecavir tablets to...
- The federal contract IDV award is for Acetazolamide Tablets, a pharmaceutical product, with Avkare LLC as the prime contractor. The contract was awarded by the VA National Acquisition Center, a civilian agency, and does not utilize any set-asides. This is a single-award Indefinite Delivery Contract with a ceiling value of $2,075,624.60 and a period of performance from July 31, 2022 to July 30, 2026, including four one-year option periods. The contract aims to provide an uninterrupted supply of...
- The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Avkare, LLC on February 23, 2019. The contract has a potential value of $2.29M and a period of performance from February 23, 2019 through February 22, 2024, consisting of a base year and four option years. Under the contract, Avkare will supply tenofovir disoproxil fumarate tablets to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service through their...
- The Department of Veterans Affairs National Acquisition Center awarded an Indefinite Delivery Contract (IDC) to Avkare LLC, a pharmaceutical and medical supply company, for the procurement of Ranolazine Tablets, SA. The contract has a ceiling value of $26,094,915.10 and a period of performance from November 20, 2020 through November 19, 2021, with four one-year option periods. The contract aims to provide an uninterrupted supply of Ranolazine Tablets to the VA, Department of Defense, Bureau of...
- Avkare LLC was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on August 9, 2021, with a ceiling value of $5.7 million and an ultimate completion date of August 8, 2026. The contract covers the supply of Montelukast HCL chewable tablets, a leukotriene receptor antagonist commonly used in the treatment of asthma and allergic rhinitis. The base year runs from August 9, 2021, through August 8, 2022, followed by four one-year...
- This single-award Indefinite Delivery Contract (IDC) was issued by the National Acquisition Center, a civilian agency of the U.S. Department of Veterans Affairs (VA), to Avkare LLC, a pharmaceutical and medical supply company based in Tennessee. The $11.95 million contract has a 1-year ordering period from 12/11/2022 to 12/10/2023, with four 1-year option periods, for a total potential period of performance through 12/10/2025. The contract is to provide an uninterrupted supply of Acitretin...
- Avkare LLC was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on June 17, 2025, with a ceiling value of $20.31 million to supply Abiraterone Acetate 250 milligram tablets. The contract structure includes a one-year base period with four one-year option periods, extending through June 16, 2026. This procurement is unrestricted with no small business set-aside designation, and the contract will support multiple federal...
- This Indefinite Delivery Contract represents a single-award procurement issued by the Department of Veterans Affairs National Acquisition Center to supply Metformin Hydrochloride 24-hour sustained-release tablets to multiple federal healthcare agencies. The contract, valued at $90.7 million with a base period extending from December 30, 2025, through December 29, 2026, includes four one-year option periods, establishing potential contract performance through December 2030. The prime...
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite delivery contract to Avkare, LLC for the procurement of mesalamine tablets. The contract has a one-year base period and four one-year option periods, with a potential value of $22,433,820. The contract aims to provide an uninterrupted supply of mesalamine tablets to the VA, DoD, Bureau of Prisons, and Indian Health Service through the respective pharmaceutical prime vendor programs. The original solicitation sought mesalamine tablets in 1200mg tablets with an estimated annual requirement of over 27,000 bottles to treat conditions such as ulcerative colitis and Crohn's disease in veterans and other beneficiaries. The contract was awarded without a set-aside and originated from a July 2019 pre-solicitation notice. The notice indicated the VA intended to issue a request for proposal for an unrestricted procurement of mesalamine tablets to establish a single-source supply. Interested offerors were advised to monitor the federal business opportunities website for solicitation details. The solicitation was subsequently issued in July 2019 in commercial item format according to Federal Acquisition Regulation Part 12 for evaluation of proposals.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Other Administrative Action | $0 | 4/1/21 | |
| P00002 | Rerepresentation of Non-Novated Merger/Acquisition | $0 | 4/15/20 | |
| P00001 | Vendor DUNS or Name Change - Non-Novation | $0 | 4/15/20 | |
| Not listed | Not listed | $0 | 2/10/20 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Mesalamine 1200mg Tablets (VA-19-00033043) | 36E79719R0020 | Department of Veterans Affairs National Acquisition Center | Pre-Solicitation 1/1 | 7/2/19, 1:59 PM |